GSK announced Tuesday it will acquire Nuvalent, a cancer drug developer, for $10.6 billion. CEO Luke Miels, six months into…
Read More

GSK announced Tuesday it will acquire Nuvalent, a cancer drug developer, for $10.6 billion. CEO Luke Miels, six months into…
Read MoreItaly's largest banking group, Intesa Sanpaolo, launched an unsolicited €30.6 billion ($35 billion) cash-and-share bid on Monday, June 8, to…
Read More
Israeli startups raised approximately $940 million across 17 funding rounds in May, driven primarily by artificial intelligence and defense technology.…
Read More
The UK may join a €4 billion ($4.65 billion) EU equity investment fund designed to support startups, according to EU…
Read More
Iran's 73-day internet blackout has triggered severe economic devastation, with officials reporting 1 million direct job losses and an estimated…
Read More
Stellantis unveiled a €60 billion (US$70 billion) turnaround strategy on Thursday, centered on launching 60 new models and refocusing investment…
Read More
Mistral AI co-founder and CEO Arthur Mensch has issued a stark warning about Europe's growing dependence on American technology, telling…
Read More
Argentum AI has signed a $2.5 billion agreement with cloud gaming company Boosteroid and real estate developer DL Invest Group…
Read More
Chinese clean technology companies abandoned approximately $2.8 billion in planned U.S. manufacturing projects in 2025, according to Rhodium Group, as…
Read MoreBrown-Forman, maker of Jack Daniel's whiskey, has rejected a $15 billion takeover bid from rival American spirits company Sazerac, a…
Read More